TMEFF2 and endometrial cancer: The univariate Kaplan–Meier analysis showed that the overall recurrence-free survival was significantly lower in patients with endometrial cancer with a high TMEFF2 expression compared to patients with a low TMEFF2 expression (p = 0.015).